Company Focus

Merck & Co

Latest Merck & Co News

Pulmonary arterial hypertension market to reach $9.3 billion in 7MM by 2034
Pharmaceutical
The pulmonary arterial hypertension (PAH) market across the seven major markets (7MM: USA, France, Germany, Italy, Spain, UK and Japan) is poised to grow at a compound annual growth rate (CAGR) of 2.0% from $7.6 billion in 2024 to $9.3 billion in 2034.   7 July 2025


Latest News & Features of interest to Merck & Co

Latest Related Ones To Watch News

US CAR-T focused biotech CARGO Therapeutics today announced that it has entered into a definitive merger agreement with Concentra Biosciences, initially worth roughly $200 million. The news sent CARGO’s stock up as much as 9.6% to $4.81 in pre-market activity.   8 July 2025

More in M&A >


Related Ones to Watch Companies

Reset all filters
Refine Search